News & features Read the latest Neuro News
The MBI's newsroom is a hub for all neuro-related news at UF, including stories, features & media coverage.
MBi News
FDA approves new ALS drug tested in clinical...
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
College implements well-being index targeting...
Drs. Christina Bulleit and Lisa Merlo lead efforts to help residents, fellows manage their mental health.
UF neurologist co-leading landmark study on...
Study co-led by Dr. Brandon Zielinski aims to shed new light on how autism is affected by the aging process.
Researchers In the spotlight
UF neurologist co-recipient of Tom Isaacs...
Drs. Michael Okun and Ray Dorsey were joint recipients of award recognizing researchers who have significantly impacted the lives of people living...
UF awards distinction to female College of...
Dr. Sara Jo Nixon highlighted in The Independent Florida Alligator for earning highest faculty honor at UF.
Neuroscientist named to UF Foundation Term...
Dr. Adam Woods awarded professorship to support UF’s preeminence goals and advance research efforts.
Features & Video Highlights
MBI Rising Stars
A video series highlighting up-and-coming neuro researchers at the University of Florida.
MBI Behind the Scenes
It takes a village to keep the MBI research community running smoothly. We’re highlighting some of the key staff members driving our efforts.
UF Women of Neuro
We are highlighting some of the incredible women leading our neuro research initiatives at UF. Check out some of our fearless leaders below!
Connect With the MBI
Newsletter
Join an Email list!
Interested in receiving important updates about the MBI or our newsletter? Click the link below to sign up for one of our listservs.
CONNECTING
Read our Newsletter
Published quarterly, the MBI e-newsletter, The Brainstorm, will help you stay up-to-date with all the latest happenings at the MBI.
GIVING
Support the MBI
If you are looking for a way to make a difference, for a way to fight back against brain cancer; cognitive aging; pain; psychiatric disorders; stroke; traumatic brain and spinal cord injury; and neurological diseases like Alzheimer’s, epilepsy, dystonia, Parkinson’s and ALS, then please partner with us in our mission.